Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Medicine|August 7, 2016
Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CTJacob Farnebo, Agnes Wadelius, Per Sandström, et al.
Investigational New Drugs|March 21, 2022
Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cellsMarcela Márquez, Karl Holmberg Olausson, Ayodele Alaiya, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2016
Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up studyKhairul Majumder, Sten Nilsson, Hemming Johansson, et al.
Scandinavian Journal of Urology and Nephrology|March 8, 2003
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2Amir Sherif, Erkki Rintala, Oddvar Mestad, et al.
Anticancer Research|July 28, 2004
Charge-dependent targeting: results in six tumor cell linesMarcela Márquez, Sten Nilsson, Lena Lennartsson, et al.
European Urology|March 24, 2004
Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studiesAmir Sherif, Lars Holmberg, Erkki Rintala, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy?Josef Nilsson, Karl Mikael Kälkner, Lars Berg, et al.
International Journal of Oncology|October 31, 2014
Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalitiesMarie Hjälm-Eriksson, Bo Lennernäs, Anders Ullén, et al.
Brachytherapy|February 8, 2007
Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancerKarl Mikael Kälkner, Emil Bengtsson, Simone Eriksson, et al.
Acta Oncologica (Stockholm, Sweden)|September 5, 2022
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiationMarie Hjälm-Eriksson, Anders Ullén, Sten Nilsson, et al.
Pageof 11